MarketInOut Stock Screener Log In | Sign Up
 

Cardio Diagnostics Holdings Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Cardio Diagnostics Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.05 mln
Float2.83 mln
Earnings Date11/12/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.67
Highly reliable

Relative Strength

25 / 100
Underperforming

Debt / Equity

0.05
Debt-free

Pre-Tax Margin

-44,772%
Severely loss-making

ROE

-78.55
Deeply negative

Business Description

Cardio Diagnostics Holdings Inc. is a Chicago-based company founded in 2017 that creates blood tests and digital tools to help doctors identify and manage heart disease risk. Its products use genetic and epigenetic data to give clinicians a clearer picture of a patient's cardiovascular health, supporting earlier and more informed treatment decisions. The company works with telemedicine services, specialty medical practices, and employers, and also offers research solutions to help pharmaceutical companies develop new heart disease treatments.

Key Fundamentals

EPS-2.79
ROE-78.55
RPS0.01
ROIC-174
ROA-63.18
Interest Cover-525
EBITDA, mln-6.06
EV / EBITDA-0.06
EV / EBIT-0.06
Revenue, mln0.01
EV / Revenue28.07

Quote Details

Last 1.69
Change -0.02 (-1.17%)
Open 1.80
Volume 9,480
Turnover 16,021
Average Volume 29,082

Financial Ratios

Pre-Tax Profit Margin-44,772
Leverage Ratio1.07
Current Ratio17.15
Price / Book0.75
Price / Tangible Book0.87
Debt / Equity0.05
Price / Sales271

Financial Strength

Altman Z-Score-0.92
Piotroski F-Score 3 / 9
Beneish M-Score-3.67
Short Ratio0.03
Short % of Float0.03

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 52 / 100   
1 Month -11.52% 27 / 100   
2 Months 3.68% 80 / 100   
6 Months -7.14% 39 / 100   
1 Year -59.18% 15 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog